Article

Systemic adverse effects induced by the BNT162b2 vaccine are associated with higher antibody titers from 3 to 6 months after vaccination

2022-01-24

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Objective</h4> We aimed to determine the relationship between vaccine-related adverse effects and antibody (Ab) titers from 3 to 6 months after the second dose of the BNT162b2 coronavirus disease 2019 (COVID-19) mRNA vaccine (Pfizer/BioNTech) in Japan. <h4>Methods</h4> We enrolled 378 healthcare workers (255 women, 123 men) whose Ab titers 3 and 6 months after the second dose were analyzed in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7538482a-222e-5d45-a31c-8c5c2d602b53
DOI: 10.1101/2022.01.23.22269706

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Systemic adverse effects induced by the BNT162b2 vaccine are associated with higher antibody titers from 3 to 6 months after vaccinationDOI 10.1101/2022.01.23.22269706Read

Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workersSemantic proximity Read

Correlates of Neutralizing/SARS-CoV-2-S1-Binding Antibody Response With Adverse Effects and Immune Kinetics in BNT162b2-Vaccinated IndividualsSemantic proximity Read

Safety of the Fourth COVID-19 BNT162b2 mRNA (Second Booster) VaccineSemantic proximity Read

Sex differences in symptoms following the administration of BNT162b2 mRNA Covid-19 Vaccine in Children below 5 Years of age in Germany (CoVacU5): a retrospective cohort studySemantic proximity Read

Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case seriesSemantic proximity Read

Bivalent BNT162b2mRNA original/Omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared to the monovalent COVID-19 boosterSemantic proximity Read

Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staffs with a history of allergySemantic proximity Read

Induction of immune response after SARS-CoV-2 mRNA BNT162b2 vaccination in healthcare workersSemantic proximity Read

Safety and Adverse Effects of the COVID-19 Vaccine Among the General Japanese PopulationSemantic proximity Read

Impact of BNT162b2 mRNA Vaccination on the Development of Short and Long-term Vaccine-Related Adverse Events in Inflammatory Bowel Disease: A Multi-Center Prospective StudySemantic proximity Read

Baseline Enrichment of T and NK Cell Genes Predispose to mRNA Vaccine-Associated Systemic Adverse Events that Can Be Alleviated by Altering the Route of VaccinationSemantic proximity Read

Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from GreeceSemantic proximity Read